Topics spanned from GLP-1s to aorto-coronary bypass without surgery, Lp(a)’s extended reach, US dietary guidelines, and more.

Gene-editing therapy, ACS guidelines, and the death of Dimitrios Karmpaliotis were some of TCTMD’s most-read stories this year.

CLOSURE-AF and CREST-2 were widely read, but stories on GLP-1s, DOACs in AF, and a new PCSK9 inhibitor were popular, too.

Drugs, devices, and even coffee made it into the mix as we move from a busy meeting season to the restful holidays ahead.

There are 27 late-breaking science presentations, more with basic science, as well as debates and discussions around cardiac care.

It’s the height of meeting season! All our most-read stories this month hailed from the news team’s on-site coverage.

There’s no shortage of late-breaking trials and science, plus live cases, innovation forums, and AI-focused sessions, this year.

The most-read article this month was a look at the new European valve guidelines, with the list fleshed out by news from ESC 2025.

Guidelines galore, excitement over ESC 2025, radiation protection, antiplatelets, and more—this month has it all.

With 10 Hotline sessions, and 42 late-breaking science sessions, there is no shortage of new data for the practicing cardiologist.